Illumina (ILMN)
A trailblazer in genomics, Illumina drives progress in DNA sequencing and precision medicine. Its platforms underpin much of the biotech sector’s research, offering scalable tools that fuel personalized healthcare, population genomics, and next-gen diagnostics — with the potential to redefine how humanity understands itself.
Year Invested
2023
Industry
Biotechnology
Status
Active